Web notes  

August 2021
FUNDING OPPORTUNITIES- Back

COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.


Kleberg Foundation Medical Research Program

Internal deadline: August 13, 2021

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation is seeking highly innovative and groundbreaking medical research proposals in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. The Foundation focuses on basic science and some translational - not clinical research. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field. A highly qualified scientific advisory committee will review all proposals.

Applicants must be faculty-eligible to serve as a Principal Investigator. Johns Hopkins may submit one nominee for this $1,000,000 award.

Interested applicants should complete their application at the following link: https://jhu.infoready4.com/#competitionDetail/1846602.

Internal Nomination Process:

Requirements are listed below.

  1. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins)
    Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit
  2. NIH-format biosketch of investigator, including current external research support and publications (5-page limit)
  3. Budget (two pages maximum)

Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.


Greenwall Foundation Faculty Scholars Program

Internal deadline: August 19, 2021

The Greenwall Faculty Scholars Program in Bioethics is a career development award to enable junior faculty members to carry out innovative bioethics research. It supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical, biomedical, and public health decision-making, policy, and practice, and creates a community that enhances future bioethics research by Scholars and Alumni/ae.

Eligibility & Requirements:

  • Applicants must be junior faculty members at a university or non-profit research institute that has tax-exempt status in the United States.
  • Applicants must hold a faculty appointment that allows at least 50 percent of their effort to perform research (often this is a faculty position with at least a 60 percent appointment in a tenure-track position or its equivalent).
  • Priority will be given to applicants who have not yet been considered for tenure or an equivalent promotion; whose research will have an impact on public policy, biomedical research, or clinical practice; and who will make important contributions to the field of bioethics over their careers.
  • Faculty Scholars will be selected on the basis of their achievements, the strength of their research project, their commitment to the field of bioethics, and support from their home institution, including after the end of this award.
  • Priority will be given to applicants whose research addresses innovative ideas and/or emerging topics.

Internal Nomination Process:
Interested applicants should submit the documents below at the following link: https://jhu.infoready4.com/#competitionDetail/1847922.

Requirements are listed below.

  1. A 3-page, single-spaced letter of intent, with one-inch margins and font size no smaller than 12 point, that includes: a description of the research proposal, particularly its significance; how the research will be carried out and how it is likely to have an impact on clinical, biomedical, and public health decision-making, policy, and practice; a personal statement describing the applicant's goals in the field of bioethics.
  2. A CV, no more than five single-spaced pages

Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.


NIH Collaborative Program for Multidisciplinary Teams (RM1 Clinical Trial Optional)

Internal deadline: September 7, 2021

This announcement encourages Collaborative Program Grant applications that propose to conduct research to address complex and challenging biomedical problems, important for the mission of the National Institute of General Medical Sciences (NIGMS), through deeply integrated, multidisciplinary research teams. The Grant is designed to support research in which funding a team of interdependent investigators offers significant advantages over support of individual research project grants. Applications should address critical issues and be sufficiently challenging, ambitious, and innovative that objectives could not be achieved by individual investigators. Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations.

Eligibility & Requirements:

Consultation with relevant staff at least 10 weeks prior to the application due date is strongly encouraged.

  • A multiple PD/PI application is required and must include a minimum of 3 and a maximum of 6 PD/PIs who are all necessary to provide sufficient research capacity and the relevant expertise to address the proposed scientific problem.
  • Early Stage Investigators and new investigators who participate as PD/PIs will lose their early stage status for future NIH applications, but ESI leads of pilot studies will not lose ESI status.
  • PD/PIs who have an active NIGMS R35 award can participate as PD/PIs as part of the 51% effort on their current R35 award but may not receive additional funds from this award.
  • Applicants with substantial unrestricted research support may receive funding from this award as their one NIGMS grant award, or may participate in an unfunded advisory or consulting role without loss of their ability to receive one funded NIGMS grant, consistent with NIGMS policies.

Internal Nomination Process:

  1. JHU Limited Submission Cover Sheet
  2. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit)
  3. Curriculum Vitae of investigator, including current external research support and publications
  4. Budget (two pages maximum)
    Questions? Comments? Email the Research Development Team at resapp@jhu.edu.


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use.


Return to top of Funding Opportunities

 
   
August 2021 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Third Thursdays with the ICTR Lecture Series - ICTR Clinical Research Units
Coronavirus Research Billing Notices and FAQ
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
Animal Exposure Surveillance Program (AESP)
Research Safety Reminder--Anesthesia Gas Filter Canisters
Johns Hopkins Occupational Health Services
Dual Use Research of Concern (DURC) policies
COVID-19 Funding Opportunities
Kleberg Foundation Medical Research Program
Greenwall Foundation Faculty Scholars Program
NIH Collaborative Program for Multidisciplinary Teams (RM1 Clinical Trial Optional)
Michael J. Fox Foundation (MJFF) Challenge
Updated Guidance from NIH on COVID-19 Flexibilities for Applicants and Recipients
COVID-19 and Research Updates
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for August, September and October

Events at the Genetics Research Core Facilities
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center